Nucleo.
Nucleo.

Advanced AI-powered body composition analysis and tumor segmentation from medical images.

From scan to answer.
In seconds, not hours.

Our use cases

Nucleo's advanced AI technology streamlines clinical workflows across three critical areas for oncology care.

01

Body composition and sarcopenia assessment

Automatic detection and quantification of muscle mass in CT scans, providing crucial nutritional metrics for cancer patients and improving treatment efficacy.

Body composition and sarcopenia assessment example
02

Tumor Lesion Sizing

Precise and consistent measurement of tumor lesions in CT scans, enabling accurate tracking of disease progression and treatment response.

Tumor Lesion Sizing example
03

Target vs Non-Target Lesion Classification

Automated classification of lesions according to RECIST criteria, streamlining the evaluation process and enhancing reporting consistency.

Target vs Non-Target Lesion Classification example

State of the art performance

Our platform delivers incredible performance in seconds. For example, in the body composition assessment task, our accuracy, measured in Dice score similarity, is well above that of the widely used Bioelectrical Impedance Analysis (BIA).

Our body composition tool
91%
The industry standard (BIA)
75%
Our lesion segmentator
85%

Get in touch

Interested in joining our pilot program or learning more about Nucleo? Reach out to us today.

Email us directly

[email protected]